TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells.

TRAF-binding domain-containing protein (TRABID), a member of the OTU deubiquitinase family, has an important role in regulating cellular functions via deubiquitinating substrate proteins such as EZH2 and Jmjd2d. However, the mechanism of its role in the proliferation of hepatocellular carcinoma (HCC) cells has not been fully elucidated. Here, we analyzed ...
the interactome of TRABID in HepG2 cells through mass spectrometry-based proteomics and found that TRABID is associated with damaged DNA-binding protein2 (DDB2). Immunoprecipitation assay showed that the interaction of TRABID and DDB2 is mediated by their OTU domain and N-terminal region, respectively. Furthermore, TRABID deubiquitinates DDB2, and this deubiquitination effect of TRABID depends on its active site. Functionally, we showed that TRABID-mediated hepatocellular carcinoma cell proliferation is attenuated by DDB2 knockdown. Thus, our data revealed a critical role of the TRABID-DDB2 axis in the proliferation of hepatocellular carcinoma cells.
Mesh Terms:
Carcinoma, Hepatocellular, Cell Line, Cell Proliferation, DNA-Binding Proteins, Humans, Immunoprecipitation, Liver Neoplasms
Biochem Biophys Res Commun
Date: Dec. 15, 2021
Download Curated Data For This Publication
238568
Switch View:
  • Interactions 3,955